Brivekimig for crohn disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 6 May 2025: Trial registered, NCT06958536
  2. 3 Jun 2025: Trial started, NCT06958536

The trials

NCT06958536: A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease

State
Under way
Phase
Phase 2
People
99 planned
Started
3 Jun 2025
Primary completion
17 Dec 2026
Arms
Brivekimig Dose Regimen A, Brivekimig Dose Regimen B
Results
None posted
  1. 6 May 2025: Trial registered
  2. 3 Jun 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.